Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

PENTAX Medical Names New Chief Medical Officer And Appoints Chief Operating Officer
By: PR Newswire Association LLC. - 24 Apr 2015Back to overview list

MONTVALE, N.J., April 24, 2015 /PRNewswire/ -- PENTAX Medical, a leader in the healthcare industry for endoscopic imaging, has announced that Mark Koppel, MD, will join the organization as Chief Medical Officer of the Americas. In this position, Mark will be responsible for strengthening PENTAX Medical's interface between our products, our patients and the medical community. "Mark's background as both a medical doctor and an attorney strengthens our PENTAX Americas leadership and organizational capabilities as we deliver our current business initiatives and make sure we are in the best position possible to serve our customers," said Chris Burton, PENTAX President of the Americas.

Mark is a healthcare executive with over a decade of both clinical and commercial experience. Most recently, he was the Chief Medical Officer at Health Sciences Outcomes. Previously, he held positions including Resident Physician at Rush University Medical Center and Resurrection Medical Center, and also brings to the table extensive sales and marketing experience from his time at General Electric. He earned his MD degree at the University of Tennessee, College of Medicine, and holds a JD degree from the University of Arkansas School of Law.

PENTAX Medical is also pleased to announce that Gene Merante has been appointed Chief Operating Officer (COO) of the Americas, a position he will take on in addition to his current role as Chief Financial Officer (CFO/EVP) of the Americas. In his new role, Gene will be instrumental in leading and ensuring the Americas region operates in the most efficient manner possible. "We look forward to harnessing Gene's industry experience and ability to guide our organization well beyond the area of finance," notes President of the Americas, Chris Burton.

Gene joined PENTAX Medical in 2006 as Vice President of Finance and since that time has taken on increasing levels of responsibility.  He was promoted to Vice President and Treasurer for PENTAX of America, Inc. and PENTAX Canada, Inc. in 2008, and was named CFO and Executive Vice President for the Americas in 2010.

About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading-edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. PENTAX Medical employees represent the diverse countries where we do business, allowing us to provide innovative solutions tailored to meet local needs.

SOURCE PENTAX Medical

Copyright 2015 PR Newswire Association LLC. Back to overview list
to the top ↑